✦ LIBER ✦

Predictors for the 5-year risk of serious infections in patients with rheumatoid arthritis treated with anti-tumour necrosis factor therapy: a cohort study in the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry

✍ Scribed by van Dartel, S. A. A.; Fransen, J.; Kievit, W.; Dutmer, E. A. J.; Brus, H. L. M.; Houtman, N. M.; van de Laar, M. A. F.; van Riel, P. L. C. M.

Book ID: 119969221
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 104 KB
Volume: 52
Category: Article
ISSN: 1462-0324
DOI: 10.1093/rheumatology/kes413

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence and Risk Factors for Serious I

Incidence and Risk Factors for Serious Infection in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety

✍ KOMANO, Y.; TANAKA, M.; NANKI, T.; KOIKE, R.; SAKAI, R.; KAMEDA, H.; NAKAJIMA, A 📂 Article 📅 2011 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 337 KB

Anti–tumor necrosis factor α therapy and

Anti–tumor necrosis factor α therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis

✍ Sebastian Schneeweiss; Soko Setoguchi; Michael E. Weinblatt; Jeffrey N. Katz; Je 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

## Abstract ## Objective To assess the association between the initiation of anti–tumor necrosis factor α (anti‐TNFα) therapy and the risk of serious bacterial infections in routine care. ## Methods This was a cohort study of patients with rheumatoid arthritis (RA) in whom specific disease‐modif

Comparative responsiveness of the EuroQo

Comparative responsiveness of the EuroQol-5D and Short Form 6D to improvement in patients with rheumatoid arthritis treated with tumor necrosis factor blockers: Results of the Dutch Rheumatoid Arthritis Monitoring registry

✍ Laurien Buitinga; Louise M. A. Braakman-Jansen; Erik Taal; Wietske Kievit; Henk 📂 Article 📅 2012 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 119 KB

The risk of serious infection in patient

The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database

✍ Sakai, Ryoko; Cho, Soo-Kyung; Nanki, Toshihiro; Koike, Ryuji; Watanabe, Kaori; Y 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 250 KB

Association between anti-tumour necrosis

Association between anti-tumour necrosis factor therapy and risk of ischaemic stroke in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registers-Rheumatoid Arthritis (BSRBR-RA)

✍ Low, Audrey SL; Lunt, Mark; Mercer, Louise K; Galloway, James B; Davies, Rebecca 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 47 KB

Long-term anti-TNF therapy and the risk

Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry

✍ Atzeni, Fabiola; Sarzi-Puttini, Piercarlo; Botsios, Costantino; Carletto, Antoni 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 180 KB